CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $692 | -99.9% | 23,503 | 0.0% | 0.03% | -3.6% |
| Q2 2023 | $766,667 | +97316.4% | 23,503 | +5.1% | 0.03% | -6.7% |
| Q1 2023 | $787 | -39.0% | 22,361 | -20.6% | 0.03% | -41.2% |
| Q4 2022 | $1,291 | -99.9% | 28,172 | +6.0% | 0.05% | -7.3% |
| Q3 2022 | $1,288,000 | +27.8% | 26,574 | +3.6% | 0.06% | +37.5% |
| Q2 2022 | $1,008,000 | +52.7% | 25,643 | -15.9% | 0.04% | +66.7% |
| Q3 2020 | $660,000 | – | 30,491 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |